Showing 2031-2040 of 7454 results for "".
In-person vs. Telehealth: Patient Preference and the Future of Engagement
https://practicaldermatology.com/topics/practice-management/in-person-vs-telehealth-patient-preference-and-the-future-of-engagement/23502/As Americans emerge from the pandemic, evidence suggests that patients may appreciate choices in how they interact with physicians.Representation in Marketing and Outreach
https://practicaldermatology.com/series/diversity-and-equity-in-dermatology/representation-in-marketing-and-outreach/19916/There is an apparent low rate of participation in aesthetic procedures among patients of color. Does this reflect a lack of interest or does limited representation in marketing and educational materials leave patients feeling that aesthetic interventions aren't meant for them? Panelists discuss theDERM2020 Content Recap: Brad Glick, DO, MPH
https://practicaldermatology.com/conferences/dermatology-education-foundation-derm-2020/derm2020-content-recap-brad-glick-do/19840/DERM2020 Faculty Brad Glick, DO, MPH shares his thoughts on DERM2020 and some of the presentations around COVID.Emerging Technology: A Look at Nano-Pulse Stimulation
https://practicaldermatology.com/topics/skin-cancer-photoprotection/emerging-technology-a-look-at-nano-pulse-stimulation/23336/NPS is emerging as a novel technology platform for general and aesthetic dermatology.COVID-19 Impact: Interrupted EBD Regimens
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/covid-19-impact-on-interrupted-ebd-regimens/19764/Aesthetic treatments aren't considered essential at this time, but what do you do about patients who were in the middle of a series of energy-based treatments? Eric Bernstein, MD says the good news is that the skin doesn't forget. Now is a great time to focus on topical therapies that complement in-The Microbiome: What Do We Know Now?
https://practicaldermatology.com/topics/atopic-dermatitis/the-microbiome-what-do-we-know-now/23122/Questions and answers about the microbiome and its role in influencing cutaneous health.MIPS: The Secret to His Success
https://practicaldermatology.com/topics/practice-management/mips-the-secret-to-his-success/23117/Windsor Dermatology’s Dr. David Nieves shares his successful MIPS action plan.Understanding the Legalities of Off-label Use
https://practicaldermatology.com/topics/practice-management/understanding-the-legalities-of-off-label-use/20317/Off-label use is part and parcel of dermatology practice, but confusion about the practice persists. Here's what you should know.Valeant's Plan for Derm; VCS Highlights
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-valeant-s-plan-for-derm-vcs-highlights/18587/Amid reports that its Obagi and Solta units may be sold off, Valeant Pharmaceuticals is assuring investors that the company is focused on the future and has plans to fix its dermatology unit. Vegas Cosmetic Surgery has wrapped up its 12th program, gathering dermatologists, plastic surgeons, facial pFDA Warns on Expression; Lilly's Ixekizumab Data Promising
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-fda-warns-on-expression-lilly-s-ixekizumab-data-promising/19093/Lilly's Ixekizumab phase III data look good for psoriasis, and the FDA warns on improper use of Expression hyaluronic acid as a dermal filler. Plus, Sitavig is available for herpes labialis, and Syneron's laser gets an onychomycosis clearance.